PYC pyc therapeutics limited

Ann: Board Renewal, page-5

  1. ds
    7,131 Posts.
    Janssen (ring a bell?) then Amgen Head of Biologics (Amgen is bigger than the largest ASX listed company) - this is a serious hitter. Another ex Amgen in oncology and recently involved directly with PYC. Drug development expertise and connections all over the world for both. Biggest reason I am excited is that people of this calibre only lend their names to Boards when they are pretty sure of success. PYC set out a strategy of drug devlopment on a global scale and have attracted global quality Board members who know the inside of PYC.

    Frankly these guys are about 2 notches above what I would expect PYC to be able to attract.
    Last edited by ds: 18/04/17
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.24
Change
-0.035(2.75%)
Mkt cap ! $723.2M
Open High Low Value Volume
$1.27 $1.27 $1.22 $162.1K 130.3K

Buyers (Bids)

No. Vol. Price($)
2 3818 $1.22
 

Sellers (Offers)

Price($) Vol. No.
$1.24 956 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.